<SEC-DOCUMENT>0001213900-20-013951-index.html : 20200602
<SEC-HEADER>0001213900-20-013951.hdr.sgml : 20200602
<ACCEPTANCE-DATETIME>20200602170044
ACCESSION NUMBER:		0001213900-20-013951
CONFORMED SUBMISSION TYPE:	SC 13D
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20200602
DATE AS OF CHANGE:		20200602
GROUP MEMBERS:		KFIR SILBERMAN

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Therapix Biosciences Ltd.
		CENTRAL INDEX KEY:			0001611746
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-89951
		FILM NUMBER:		20937896

	BUSINESS ADDRESS:	
		STREET 1:		4 ARIEL SHARON STREET
		STREET 2:		HASHAHAR TOWER, 16TH FLOOR
		CITY:			GIV?ATAYIM
		STATE:			L3
		ZIP:			5320047
		BUSINESS PHONE:		972-3-6167055

	MAIL ADDRESS:	
		STREET 1:		4 ARIEL SHARON STREET
		STREET 2:		HASHAHAR TOWER, 16TH FLOOR
		CITY:			GIV?ATAYIM
		STATE:			L3
		ZIP:			5320047

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			L.I.A. Pure Capital Ltd
		CENTRAL INDEX KEY:			0001749628
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		SC 13D

	BUSINESS ADDRESS:	
		STREET 1:		20 RAOUL WALENBERG ST
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6971916
		BUSINESS PHONE:		972-3-7175777

	MAIL ADDRESS:	
		STREET 1:		20 RAOUL WALENBERG ST
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6971916
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D
<SEQUENCE>1
<FILENAME>ea122591-13dpure_therapixbio.htm
<DESCRIPTION>SCHEDULE 13D
<TEXT>
Document 1 - file: ea122591-13dpure_therapixbio.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea122591ex1_therapixbio.htm
<DESCRIPTION>DEMAND LETTER TO CONVENE A SPECIAL GENERAL MEETING OF THE SHAREHOLDERS OF THE REGISTRANT, DATED JUNE 1, 2020
<TEXT>
Document 2 - file: ea122591ex1_therapixbio.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>ea122591ex2_therapixbio.htm
<DESCRIPTION>POSITION STATEMENT IN CONNECTION WITH THE DEMAND LETTER TO CONVENE A SPECIAL GENERAL MEETING OF THE SHAREHOLDERS OF THE REGISTRANT, DATED JUNE 1, 2020
<TEXT>
Document 3 - file: ea122591ex2_therapixbio.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>ea122591ex3_therapixbio.htm
<DESCRIPTION>JOINT FILING AGREEMENT BY AND AMONG L.I.A. PURE CAPITAL LTD. AND KFIR SILBERMAN, DATED JUNE 2, 2020
<TEXT>
Document 4 - file: ea122591ex3_therapixbio.htm

</DOCUMENT>
</SEC-DOCUMENT>